Condition: Asthma
Interventions: Drug: MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate); Drug: Advair (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate); Drug: Placebo
Sponsors: Mylan Inc.; Mylan Pharma UK Ltd.
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days